Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

SOPs for Specimen Collection

The following specimen collection SOPs were developed by DCTD. They standardize the methods for collecting and handling frozen needle biopsies and blood specimens for use in measurement of pharmacodynamic (PD) markers following treatment with anticancer agents.

SOP340507: Tumor Frozen Needle Biopsy Specimen Collection, Handling and Shipping for PADIS, Frederick National Laboratory for Cancer Research (FNLCR)

Collection and freezing of tumor needle biopsies for use in biomarker assays and preparation for shipment to PADIS, FNLCR
SOP340507

SOP340567: Tumor Frozen Needle Biopsy Specimen Collection, Handling and Shipment to EET Biobank

Collection and freezing of tumor needle biopsies for use in biomarker assays and preparation for shipment to EET Biobank
SOP340567

LHTP003.08.19: Streck Tube: Human Blood Collection and Specimen Submission

Collection, preparation, and shipment of 10 mL human blood specimens in Streck blood collection tubes for use in enrichment and analysis of circulating tumor cells
LHTP003.08.19

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “SOPs for Specimen Collection was originally published by the National Cancer Institute.”

Email